Player FM 앱으로 오프라인으로 전환하세요!
Developing a New Class of Therapies Based on a Natural Cargo Carrier
Manage episode 351732646 series 60790
One of the greatest challenges emerging therapies face is being able to reach the tissues and cells in the body where they need to go to provide benefit. Rather than using viral vectors or lipid nanoparticles, Evox is harnessing exosomes, a natural transporter within the body, to carry therapeutic cargo to desired targets. The company has developed platform technology to modify exosome so it can load therapeutic cargo into them to reach desired organs, the central nervous system, and intractable tissue. We spoke to Tony de Fougerolles, CEO of Evox Therapeutics, about exosomes, the company’s platform technology, and how it is using this approach to target a range of rare diseases.
566 에피소드
Manage episode 351732646 series 60790
One of the greatest challenges emerging therapies face is being able to reach the tissues and cells in the body where they need to go to provide benefit. Rather than using viral vectors or lipid nanoparticles, Evox is harnessing exosomes, a natural transporter within the body, to carry therapeutic cargo to desired targets. The company has developed platform technology to modify exosome so it can load therapeutic cargo into them to reach desired organs, the central nervous system, and intractable tissue. We spoke to Tony de Fougerolles, CEO of Evox Therapeutics, about exosomes, the company’s platform technology, and how it is using this approach to target a range of rare diseases.
566 에피소드
모든 에피소드
×플레이어 FM에 오신것을 환영합니다!
플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.